Article Text

The clock keeps ticking for intravenous methylprednisolone
  1. Florian Then Bergh
  1. Correspondence to:
 Dr Florian Then Bergh
 Department of Neurology, University of Leipzig, Liebigstrasse 22A, Leipzig, Germany; thenberf{at}

Statistics from

Patients with multiple sclerosis may benefit more from night-time rather than daytime infusion

Glass-Marmor and colleagues1 randomised 17 patients with multiple sclerosis in acute relapse to receive intravenous methylprednisolone (MP) in the morning or at night, together with infusion of placebo at the other time point, in an inpatient setting (see page 886). When admitted for a subsequent relapse, those originally treated in the morning had intravenous MP at night, and vice versa. In this way, daytime and …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles